• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二价化合物17MN在阿尔茨海默病细胞模型中通过多部位相互作用发挥神经保护作用。

Bivalent Compound 17MN Exerts Neuroprotection through Interaction at Multiple Sites in a Cellular Model of Alzheimer's Disease.

作者信息

Liu Kai, Chojnacki Jeremy E, Wade Emily E, Saathoff John M, Lesnefsky Edward J, Chen Qun, Zhang Shijun

机构信息

Department of Medicinal Chemistry, Virginia Commonwealth University, Richmond, VA, USA.

Department of Medicine, Pauley Heart Center, Division of Cardiology, Virginia Commonwealth University, Richmond, VA, USA.

出版信息

J Alzheimers Dis. 2015;47(4):1021-33. doi: 10.3233/JAD-150242.

DOI:10.3233/JAD-150242
PMID:26401780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4829378/
Abstract

Multiple pathogenic factors have been suggested to play a role in the development of Alzheimer's disease (AD). The multifactorial nature of AD also suggests the potential use of compounds with polypharmacology as effective disease-modifying agents. Recently, we have developed a bivalent strategy to include cell membrane anchorage into the molecular design. Our results demonstrated that the bivalent compounds exhibited multifunctional properties and potent neuroprotection in a cellular AD model. Herein, we report the mechanistic exploration of one of the representative bivalent compounds, 17MN, in MC65 cells. Our results established that MC65 cells die through a necroptotic mechanism upon the removal of tetracycline (TC). Furthermore, we have shown that mitochondrial membrane potential and cytosolic Ca2+ levels are increased upon removal of TC. Our bivalent compound 17MN can reverse such changes and protect MC65 cells from TC removal induced cytotoxicity. The results also suggest that 17MN may function between the Aβ species and RIPK1 in producing its neuroprotection. Colocalization studies employing a fluorescent analog of 17MN and confocal microscopy demonstrated the interactions of 17MN with both mitochondria and endoplasmic reticulum, thus suggesting that 17MN exerts its neuroprotection via a multiple-site mechanism in MC65 cells. Collectively, these results strongly support our original design rationale of bivalent compounds and encourage further optimization of this bivalent strategy to develop more potent analogs as novel disease-modifying agents for AD.

摘要

多种致病因素被认为在阿尔茨海默病(AD)的发展中起作用。AD的多因素性质也表明具有多药理学特性的化合物有可能作为有效的疾病修饰剂。最近,我们开发了一种二价策略,将细胞膜锚定纳入分子设计中。我们的结果表明,二价化合物在细胞AD模型中表现出多功能特性和强大的神经保护作用。在此,我们报告了对一种代表性二价化合物17MN在MC65细胞中的作用机制探索。我们的结果表明,去除四环素(TC)后,MC65细胞通过坏死性凋亡机制死亡。此外,我们还表明,去除TC后线粒体膜电位和胞质Ca2+水平会升高。我们的二价化合物17MN可以逆转这些变化,并保护MC65细胞免受TC去除诱导的细胞毒性。结果还表明,17MN可能在Aβ物种和RIPK1之间发挥作用以产生其神经保护作用。使用17MN的荧光类似物和共聚焦显微镜进行的共定位研究表明,17MN与线粒体和内质网均有相互作用,因此表明17MN在MC65细胞中通过多位点机制发挥其神经保护作用。总的来说,这些结果有力地支持了我们对二价化合物的原始设计理念,并鼓励进一步优化这种二价策略,以开发更有效的类似物作为AD的新型疾病修饰剂。

相似文献

1
Bivalent Compound 17MN Exerts Neuroprotection through Interaction at Multiple Sites in a Cellular Model of Alzheimer's Disease.二价化合物17MN在阿尔茨海默病细胞模型中通过多部位相互作用发挥神经保护作用。
J Alzheimers Dis. 2015;47(4):1021-33. doi: 10.3233/JAD-150242.
2
Mechanistic Insight of Bivalent Compound 21MO as Potential Neuroprotectant for Alzheimer's Disease.二价化合物21MO作为阿尔茨海默病潜在神经保护剂的作用机制洞察
Molecules. 2016 Mar 25;21(4):412. doi: 10.3390/molecules21040412.
3
Bivalent ligands incorporating curcumin and diosgenin as multifunctional compounds against Alzheimer's disease.含有姜黄素和薯蓣皂苷元的二价配体作为抗阿尔茨海默病的多功能化合物。
Bioorg Med Chem. 2015 Nov 15;23(22):7324-31. doi: 10.1016/j.bmc.2015.10.032. Epub 2015 Oct 24.
4
Discovery of 5-(4-hydroxyphenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide as a neuroprotectant for Alzheimer's disease by hybridization of curcumin and melatonin.通过姜黄素与褪黑素杂交发现5-(4-羟基苯基)-3-氧代戊酸[2-(5-甲氧基-1H-吲哚-3-基)乙基]酰胺作为阿尔茨海默病的神经保护剂
ACS Chem Neurosci. 2014 Aug 20;5(8):690-9. doi: 10.1021/cn500081s. Epub 2014 May 22.
5
"Clicked" bivalent ligands containing curcumin and cholesterol as multifunctional abeta oligomerization inhibitors: design, synthesis, and biological characterization.含姜黄素和胆固醇的“点击”二价配体作为多功能 Aβ寡聚体抑制剂的设计、合成与生物学特性。
J Med Chem. 2010 Aug 26;53(16):6198-209. doi: 10.1021/jm100601q.
6
Synthetic Curcumin Analogs as Inhibitors of β -Amyloid Peptide Aggregation: Potential Therapeutic and Diagnostic Agents for Alzheimer's Disease.合成姜黄素类似物作为β-淀粉样肽聚集的抑制剂:阿尔茨海默病的潜在治疗和诊断药物。
Mini Rev Med Chem. 2015;15(13):1110-21. doi: 10.2174/138955751513150923101841.
7
Design, synthesis, and biological evaluation of curcumin analogues as multifunctional agents for the treatment of Alzheimer's disease.设计、合成及生物评价姜黄素类似物作为治疗阿尔茨海默病的多功能药物。
Bioorg Med Chem. 2011 Sep 15;19(18):5596-604. doi: 10.1016/j.bmc.2011.07.033. Epub 2011 Jul 24.
8
Syntheses And Evaluation Of Asymmetric Curcumin Analogues As Potential Multifunctional Agents For The Treatment Of Alzheimer's Disease.不对称姜黄素类似物作为治疗阿尔茨海默病潜在多功能药物的合成与评价
Curr Alzheimer Res. 2015;12(5):403-14. doi: 10.2174/1567205012666150504151120.
9
Development of bivalent compounds as potential neuroprotectants for Alzheimer's disease.开发二价化合物作为阿尔茨海默病的潜在神经保护剂。
Bioorg Med Chem Lett. 2019 Aug 1;29(15):1957-1961. doi: 10.1016/j.bmcl.2019.05.035. Epub 2019 May 18.
10
l-3-n-Butylphthalide attenuates β-amyloid-induced toxicity in neuroblastoma SH-SY5Y cells through regulating mitochondrion-mediated apoptosis and MAPK signaling.L-3-正丁基苯酞通过调节线粒体介导的凋亡和丝裂原活化蛋白激酶(MAPK)信号通路减轻β-淀粉样蛋白诱导的神经母细胞瘤SH-SY5Y细胞毒性。
J Asian Nat Prod Res. 2014;16(8):854-64. doi: 10.1080/10286020.2014.939586.

引用本文的文献

1
Neuroprotection against beta-amyloid toxicity by the novel estrogen receptor modulator STX requires convergent signaling pathways.新型雌激素受体调节剂STX对β-淀粉样蛋白毒性的神经保护作用需要多条信号通路协同作用。
Front Mol Neurosci. 2025 Sep 12;18:1670646. doi: 10.3389/fnmol.2025.1670646. eCollection 2025.
2
Therapeutic implications of necroptosis activation in Alzheimer´s disease.坏死性凋亡激活在阿尔茨海默病中的治疗意义
Alzheimers Res Ther. 2024 Dec 26;16(1):275. doi: 10.1186/s13195-024-01649-8.
3
Merging cultures and disciplines to create a drug discovery ecosystem at Virginia commonwealth university: Medicinal chemistry, structural biology, molecular and behavioral pharmacology and computational chemistry.

本文引用的文献

1
Carnosic acid attenuates apoptosis induced by amyloid-β 1-42 or 1-43 in SH-SY5Y human neuroblastoma cells.迷迭香酸可减轻淀粉样蛋白β1-42或1-43在SH-SY5Y人神经母细胞瘤细胞中诱导的细胞凋亡。
Neurosci Res. 2015 May;94:1-9. doi: 10.1016/j.neures.2014.12.003. Epub 2014 Dec 12.
2
Necroptosis: is there a role for mitochondria?细胞坏死性凋亡:线粒体是否发挥作用?
Front Physiol. 2014 Aug 26;5:323. doi: 10.3389/fphys.2014.00323. eCollection 2014.
3
Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.线粒体活性氧(ROS)与ROS诱导的ROS释放。
弗吉尼亚联邦大学融合文化与学科,创建药物发现生态系统:药用化学、结构生物学、分子和行为药理学以及计算化学。
SLAS Discov. 2023 Sep;28(6):255-269. doi: 10.1016/j.slasd.2023.02.006. Epub 2023 Feb 28.
4
Preclinical Evidence for the Interplay between Oxidative Stress and RIP1-Dependent Cell Death in Neurodegeneration: State of the Art and Possible Therapeutic Implications.氧化应激与RIP1依赖性细胞死亡在神经退行性变中的相互作用的临床前证据:现状与可能的治疗意义
Antioxidants (Basel). 2021 Sep 24;10(10):1518. doi: 10.3390/antiox10101518.
5
Structural understanding of 5-(4-hydroxy-phenyl)-N-(2-(5-methoxy-1H-indol-3-yl)-ethyl)-3-oxopentanamide as a neuroprotectant for Alzheimer's disease.5-(4-羟基苯基)-N-(2-(5-甲氧基-1H-吲哚-3-基)乙基)-3-氧代戊酰胺作为阿尔茨海默病神经保护剂的结构研究。
Bioorg Med Chem Lett. 2021 Jul 1;43:128081. doi: 10.1016/j.bmcl.2021.128081. Epub 2021 May 5.
6
A comparison of the location in membranes of curcumin and curcumin-derived bivalent compounds with potential neuroprotective capacity for Alzheimer's disease.姜黄素和具有潜在阿尔茨海默病神经保护作用的姜黄素衍生双价化合物在膜中的位置比较。
Colloids Surf B Biointerfaces. 2021 Mar;199:111525. doi: 10.1016/j.colsurfb.2020.111525. Epub 2020 Dec 13.
7
Curcumin in Health and Diseases: Alzheimer's Disease and Curcumin Analogues, Derivatives, and Hybrids.姜黄素在健康与疾病中的应用:阿尔茨海默病与姜黄素类似物、衍生物和杂合物。
Int J Mol Sci. 2020 Mar 13;21(6):1975. doi: 10.3390/ijms21061975.
8
Development of bivalent compounds as potential neuroprotectants for Alzheimer's disease.开发二价化合物作为阿尔茨海默病的潜在神经保护剂。
Bioorg Med Chem Lett. 2019 Aug 1;29(15):1957-1961. doi: 10.1016/j.bmcl.2019.05.035. Epub 2019 May 18.
9
Design and characterization of bivalent compounds as potential neuroprotectants for Alzheimer's disease: Impact of the spacer on biological activity.作为阿尔茨海默病潜在神经保护剂的二价化合物的设计与表征:间隔基对生物活性的影响
Bioorg Med Chem Lett. 2018 Apr 1;28(6):1030-1036. doi: 10.1016/j.bmcl.2018.02.028. Epub 2018 Feb 14.
10
Insights into the Impact of a Membrane-Anchoring Moiety on the Biological Activities of Bivalent Compounds As Potential Neuroprotectants for Alzheimer's Disease.洞察膜锚定部分对二价化合物生物活性的影响,这些化合物可能是阿尔茨海默病的神经保护剂。
J Med Chem. 2018 Feb 8;61(3):777-790. doi: 10.1021/acs.jmedchem.7b01284. Epub 2018 Jan 5.
Physiol Rev. 2014 Jul;94(3):909-50. doi: 10.1152/physrev.00026.2013.
4
Discovery of 5-(4-hydroxyphenyl)-3-oxo-pentanoic acid [2-(5-methoxy-1H-indol-3-yl)-ethyl]-amide as a neuroprotectant for Alzheimer's disease by hybridization of curcumin and melatonin.通过姜黄素与褪黑素杂交发现5-(4-羟基苯基)-3-氧代戊酸[2-(5-甲氧基-1H-吲哚-3-基)乙基]酰胺作为阿尔茨海默病的神经保护剂
ACS Chem Neurosci. 2014 Aug 20;5(8):690-9. doi: 10.1021/cn500081s. Epub 2014 May 22.
5
Mitochondrial permeability transition pore is a potential drug target for neurodegeneration.线粒体通透性转换孔是神经退行性变的一个潜在药物靶点。
Biochim Biophys Acta. 2014 Aug;1842(8):1267-72. doi: 10.1016/j.bbadis.2013.09.003. Epub 2013 Sep 18.
6
Depressing mitochondria-reticulum interactions protects cardiomyocytes from lethal hypoxia-reoxygenation injury.抑制线粒体-内质网相互作用可保护心肌细胞免受致死性缺氧/复氧损伤。
Circulation. 2013 Oct 1;128(14):1555-65. doi: 10.1161/CIRCULATIONAHA.113.001225. Epub 2013 Aug 27.
7
Protective effects of peroxiredoxin 6 overexpression on amyloid β-induced apoptosis in PC12 cells.过氧化物酶 6 过表达对淀粉样β诱导的 PC12 细胞凋亡的保护作用。
Free Radic Res. 2013 Oct;47(10):836-46. doi: 10.3109/10715762.2013.833330. Epub 2013 Sep 6.
8
The multifactorial nature of Alzheimer's disease for developing potential therapeutics.阿尔茨海默病发病机制复杂,为潜在治疗方法的开发带来挑战。
Curr Top Med Chem. 2013;13(15):1745-70. doi: 10.2174/15680266113139990135.
9
2013 Alzheimer's disease facts and figures.2013 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2013 Mar;9(2):208-45. doi: 10.1016/j.jalz.2013.02.003.
10
Bivalent ligands targeting multiple pathological factors involved in Alzheimer's disease.靶向阿尔茨海默病中多种病理因素的双价配体。
ACS Med Chem Lett. 2012 Nov 8;3(11):942-946. doi: 10.1021/ml300229y. Epub 2012 Sep 11.